My name is Monika Ambrožová, and I work as data analyst at the National Screening Centre and the Institute of Biostatistics and Analyses. I primarily focus on the evaluation of screening programmes, particularly breast cancer screening and colorectal cancer screening.

Soumya Arun is a third-year PhD student based at the Centre for Cancer Screening, Prevention and Early Diagnosis at Queen Mary University of London. She has a background in medical science and oncology. Her current research focuses on optimising the external validation process for AI models developed to detect cancers from medical images. Her work aims to help bridge the gap between the development of novel AI models and their adoption in real-world clinical settings. She is particularly interested in minimising biases in AI and fostering the use of safe and ethical AI in clinical practice.

Rhian has been involved in epidemiological and trials research for over twenty-five years and has a strong research interest in screening, prevention and early detection of cancer with publications in the fields of breast, colorectal, lung and prostate cancer. She is the lead statistician for the Yorkshire Lung Screening Trial and a portfolio of prostate cancer detection studies including the UK TRANSFORM trial of prostate cancer Screening. She has worked on international studies investigating prevention strategies for infection and smoking cessation.

Stine Bisgaard Greve is a medical doctor currently training to become a radiologist and pursuing a Ph.D. focused on the use of artificial intelligence in breast cancer screening. Her research specifically explores AI applications to improve the detection and diagnosis of breast cancer during screening, aiming to enhance early detection, reduce false positives, and optimize patient outcomes.

Dr Rebecca Landy is a Research Fellow in the Clinical Epidemiology Unit, Division of Cancer Epidemiology and Genetics at the National Cancer Institute, US. Her research interests include evaluating the population level impact of lung cancer screening eligibility guidelines, HPV vaccination for the prevention of oropharyngeal cancer in US men, and non-invasive screening for oesophageal cancer.

Vibe Munk Bertelsen, MD, is a PhD student specialising in cervical cancer screening and diagnostics. Her research focuses on optimising diagnostic technologies and improving outcomes in cervical cancer prevention.

Dr. Tranberg’s research focuses on enhancing cervical cancer prevention. She has evaluated the diagnostic accuracy of self-collected vaginal and urine samples for HPV detection and cervical pre-cancer, assessed HPV vaginal self-sampling to improve screening participation among non-responders, and explored cervical cancer prevention for older women beyond current screening ages. With training in pathology, biostatistics, and epidemiology, Dr. Tranberg has led diagnostic, biomarker, and population-based intervention studies, bridging clinical practice and innovative research to advance cancer screening and prevention.

Line Gustafson is a fellow in gynecologic oncology at Aarhus University Hospital and a part-time researcher at UNICCA, Randers. Her research focuses on early detection and the use of biomarkers in the diagnosis of endometrial and cervical cancer. She completed her PhD in June 2022, which focused on cervical cancer prevention in postmenopausal women.